Skip to content

NORTHWEST BIOTHERAPEUTICS INC: 10-Q filed 2021-01-15

What NORTHWEST BIOTHERAPEUTICS INC reported in its quarterly report filed 2021-01-15 (fiscal Q3 2020): 29 published measures, 81 facts as tagged in accession 0001104659-21-004396.

This filing

Form
10-Q (quarterly report)
Filed
2021-01-15
Fiscal period
fiscal Q3 2020
Accession
0001104659-21-004396 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NORTHWEST BIOTHERAPEUTICS INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-3027,213,000USD
At 2019-12-3110,643,000USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-30239,641,000USD
At 2019-12-3155,698,000USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-30-212,428,000USD
At 2020-06-30-83,005,000USD
At 2019-12-31-45,055,000USD
At 2019-09-30-55,895,000USD
At 2019-06-30-54,238,000USD
At 2018-12-31-48,131,000USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-09-309,250,000USD
At 2019-12-31372,000USD
At 2019-03-311,970,000USD
At 2018-12-3122,224,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-194,096,000USD92
2020-01-01 to 2020-09-30-249,522,000USD274
2019-07-01 to 2019-09-30-6,371,000USD92
2019-01-01 to 2019-09-30-27,357,000USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-21,890,000USD274
2019-01-01 to 2019-09-30-25,881,000USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2020-07-01 to 2020-09-30216,000USD92
2020-01-01 to 2020-09-30788,000USD274
2019-07-01 to 2019-09-30593,000USD92
2019-01-01 to 2019-09-301,513,000USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-09-3036,876,000USD274
2019-01-01 to 2019-09-304,818,000USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-5,108,000USD274
2019-01-01 to 2019-09-30-246,000USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-30-1,090,917,000USD
At 2019-12-31-841,395,000USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-09-30819,000USD
At 2019-12-31281,000USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-47,877,000USD92
2020-01-01 to 2020-09-30-63,246,000USD274
2019-07-01 to 2019-09-30-6,585,000USD92
2019-01-01 to 2019-09-30-21,247,000USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-3012,183,000USD
At 2019-12-313,200,000USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-07-01 to 2020-09-305,540,000USD92
2020-01-01 to 2020-09-307,224,000USD274
2019-07-01 to 2019-09-30724,000USD92
2019-01-01 to 2019-09-302,267,000USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-30226,276,000USD
At 2019-12-3144,196,000USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2020-09-30654,000USD
At 2019-12-310USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-07-01 to 2020-09-3017,660,000USD92
2020-01-01 to 2020-09-3024,737,000USD274
2019-07-01 to 2019-09-303,538,000USD92
2019-01-01 to 2019-09-3010,092,000USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-30779,700,000shares
At 2019-12-31614,300,000shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2020-09-30359,000USD
At 2019-12-31836,000USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-09-304,327,000USD
At 2019-12-314,679,000USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-09-304,897,000USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2020-09-3018,874,000USD
At 2019-12-3112,723,000USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-09-30803,000USD
At 2019-12-31798,000USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-09-302,933,000USD
At 2019-12-312,828,000USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-195,336,000USD92
2020-01-01 to 2020-09-30-249,999,000USD274
2019-07-01 to 2019-09-30-5,479,000USD92
2019-01-01 to 2019-09-30-26,334,000USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-3029,321,000USD92
2020-01-01 to 2020-09-3036,822,000USD274
2019-07-01 to 2019-09-302,838,000USD92
2019-01-01 to 2019-09-309,413,000USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-07-01 to 2020-09-3017,000USD92
2020-01-01 to 2020-09-3033,000USD274
2019-07-01 to 2019-09-308,000USD92
2019-01-01 to 2019-09-3016,000USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-146,219,000USD92
2020-01-01 to 2020-09-30-186,276,000USD274
2019-07-01 to 2019-09-30214,000USD92
2019-01-01 to 2019-09-30-6,110,000USD273

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2020-01-01 to 2020-09-30745,000USD274
2019-01-01 to 2019-09-30162,000USD273

Inspect the source

Entity
NORTHWEST BIOTHERAPEUTICS INC / CIK 0001072379
Captured
2026-09-20T05:19:52.407Z
SEC response SHA-256
96ae5155e1f371497ff4e69acb04404a27b3c3c6ef981ce6f22dae4793393c44

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001072379.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))